TAE Life Sciences

About:

TAE Life Sciences is an pre-clinical biotechnology company developing comprehensive biologically-targeted radiation therapy

Website: http://taelifesciences.com/

Twitter/X: taelifesciences

Top Investors: Artis Ventures (AV), Big Sky Partners

Description:

TAE Life Sciences is developing a novel biological-targeting radiation therapy based on Boron Neutron Capture Therapy (BNCT) to improve the lives of patients with rapidly spreading, invasive and recurrent cancers that do not respond to other cancer therapies. TLS is the only company with a comprehensive target drug and neutron technology product portfolio to enable next-generation combination cancer therapy as a first-line treatment for patients globally.

Total Funding Amount:

$70M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Foothill Ranch, California, United States

Founded Date:

2017-01-01

Contact Email:

contact(AT)taelifesciences.com

Founders:

Bruce Bauer

Number of Employees:

51-100

Last Funding Date:

2020-06-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai